XML 155 R140.htm IDEA: XBRL DOCUMENT v3.25.4
Schedule II - Condensed Financial Information of Parent - Balance Sheets (Details) - USD ($)
$ / shares in Units, $ in Millions
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Investments:        
Short-term investments under securities loan agreements, including collateral delivered $ 984 $ 1,042    
Deferred income taxes 1,871 2,134    
Total assets 178,859 163,889    
Liabilities and Equity [Abstract]        
Payables under securities loan and repurchase agreements, including collateral held 1,273 1,309    
Short-term debt 586 399    
Long-term debt 2,104 2,502    
Derivatives 282 332    
Shareholders' equity:        
Preferred stock ($0.01 par value per share; $625000000 aggregate liquidation preference as of 2025 and 2024) 0 0    
Common stock ($0.01 par value per share; 900000000 shares authorized; 107,424,252 and 105,592,281 shares issued as of 2025 and 2024, respectively; 93,842,616 and 95,497,265 shares outstanding as of 2025 and 2024, respectively) 1 1    
Treasury stock (at cost; 13,581,636 and 10,095,016 shares as of 2025 and 2024, respectively) (1,010) (754)    
Additional paid-in capital 6,358 6,266    
Accumulated other comprehensive income (loss) (1,788) (2,462) $ (2,400)  
Retained earnings:        
Unappropriated 1,392 954    
Total shareholders' equity 6,817 5,788 $ 5,878 $ 4,831
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,724 and $26,536 as of 2025 and 2024, respectively; net of allowance for credit losses of $26 and $38 as of 2025 and 2024, respectively) $ 28,724 $ 26,536    
Preferred stock (0.01 par value per share; $625000000 aggregate liquidation preference as of 2025 and 2024) $ 0.01 $ 0.01    
Preferred stock (0.01 par value per share; $625000000 aggregate liquidation preference as of 2025 and 2024) $ 625 $ 625    
Common stock ($0.01 par value per share; 900000000 shares authorized; 107,424,252 and 105,592,281 shares issued as of 2025 and 2024, respectively; 93,842,616 and 95,497,265 shares outstanding as of 2025 and 2024, respectively) $ 0.01 $ 0.01    
Common stock ($0.01 par value per share; 900000000 shares authorized; 107,424,252 and 105,592,281 shares issued as of 2025 and 2024, respectively; 93,842,616 and 95,497,265 shares outstanding as of 2025 and 2024, respectively) 900,000,000 900,000,000    
Common stock ($0.01 par value per share; 900000000 shares authorized; 107,424,252 and 105,592,281 shares issued as of 2025 and 2024, respectively; 93,842,616 and 95,497,265 shares outstanding as of 2025 and 2024, respectively) 107,424,252 105,592,281    
Common stock ($0.01 par value per share; 900000000 shares authorized; 107,424,252 and 105,592,281 shares issued as of 2025 and 2024, respectively; 93,842,616 and 95,497,265 shares outstanding as of 2025 and 2024, respectively) 93,842,616 95,497,265 102,900,000 97,200,000
Treasury stock (at cost; 13,581,636 and 10,095,016 shares as of 2025 and 2024, respectively) 13,581,636 10,095,016    
Parent        
Investments:        
Equity securities, at fair value $ 0 $ 3    
Short-term investments 78 20    
Investment in subsidiaries 6 6    
Derivatives 3 14    
Investments In Subsidiaries 6,363 5,116    
Total investments 6,450 5,159    
Cash and cash equivalents 155 217    
Short-term investments under securities loan agreements, including collateral delivered 0 1    
Loans and Leases Receivable, Loans in Process 305 392    
DueFromAffiliates 3 0    
Deferred income taxes 722 819    
Other assets (net of allowance for credit losses of $0 and $1 as of 2025 and 2024, respectively) 28 6    
Total assets 7,663 6,594    
Liabilities and Equity [Abstract]        
Short-term debt 1,054 575    
Long-term debt 1,426 1,871    
Derivatives 2 22    
Due to subsidiaries and affiliates 0 2    
Other liabilities 228 119    
Total liabilities 2,710 2,589    
Retained earnings:        
Unappropriated   954    
Total shareholders' equity 4,953 4,005    
Total liabilities and shareholders' equity $ 7,663 $ 6,594